Home › Funds › Murchinson Ltd. › PTHS

Murchinson Ltd. position in PTHS

PELTHOS THERAPEUTICS INC · Health Care

Murchinson Ltd. reported holding 311,019 shares of PTHS (PELTHOS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 1.25% of its reported portfolio and ranking #21 among its reported holdings. Murchinson Ltd. has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)311.02K sh
Reported value held$6.53M
Portfolio Weight1.25%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Murchinson Ltd.'s PTHS position evolved

Murchinson Ltd. first disclosed a stake in PTHS in Q3 2025 at 280,000 shares (US$7.8M). The position peaked in Q4 2025 at 289,479 shares, worth US$9.0M. Across 5 filings, Murchinson Ltd. increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 311,019 shares valued at US$6.5M — an increase of 6,717 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 280.00K $7.84M New
Q4 2025 289.48K $8.97M Add
Q1 2026 296.31K $6.23M Add
Q2 2026 304.30K $8.60M Add
Q3 2026 311.02K $6.53M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTHS and 13F data

PTHS (PELTHOS THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in PTHS — the largest reported positions include Ikarian Capital, LLC (US$7.3M), AIGH Capital Management LLC (US$5.4M), WEXFORD CAPITAL LP (US$1.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTHS

All PTHS fund holders →

FAQ

How long has Murchinson Ltd. held PTHS?

Murchinson Ltd. has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Murchinson Ltd.'s current position in PTHS?

As of Q3 2026, Murchinson Ltd. holds 311.02K shares of PTHS (PELTHOS THERAPEUTICS INC), valued at $6.53M, representing 1.25% of its reported portfolio and ranking #21.

Has Murchinson Ltd. been buying or selling PTHS?

In the latest 13F filing (Q3 2026), Murchinson Ltd. increased its position in PTHS. The position peaked in Q4 2025 at 289.48K shares.

Which other funds hold PTHS?

Other major institutional holders of PTHS include Ikarian Capital, LLC, AIGH Capital Management LLC, WEXFORD CAPITAL LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.